Enovis Corporation (ENOV)
Makes braces, implants, and therapy devices that help people recover from injuries and joint problems.
$29.09+0.03%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+13.0%
The outlook
Enovis is trading in the upper half of its 52-week range, well above its short and long-term moving averages. Analysts overwhelmingly rate the stock a Strong Buy, with an average price target roughly 43% above the current price. The data reflects strong technical positioning and bullish analyst sentiment, though current price movement is minimal.
What’s behind the score
Analyst consensusStrong Buy — 1.3 avg of 12 analysts
Price trendAbove its 50- & 200-day averages
52-week range66% of the way from its 52-week low to high
Price targetAvg target +43% vs current price
Analyst price target
~12-month · 12 analysts$41.58average target+42.9% vs now
Now $29.09
Low $29.00High $55.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.67B
52-wk high
$34.28
52-wk low
$19.14
50-day avg
$23.86
200-day avg
$25.51
Trailing P/E
—